Myelin oligodendrocyte glycoprotein (MOG) has been identified as a target of demyelinating autoantibodies in animal models of inflammatory demyelinating diseases of the CNS, such as multiple sclerosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback